May 11, 2026

Cigna Group (CI) Stock Analysis: Potential Upside and Analyst Consensus Signal Promising Growth

The Cigna Group (NYSE: CI), a titan in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to a robust sector. With its roots dating back to..

GSK plc (GSK) Stock Analysis: Evaluating a 14.37% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find GSK plc (NYSE: GSK) an intriguing proposition. As a stalwart in the global pharmaceutical landscape, GSK’s extensive portfolio in vaccines and..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 25% Upside Potential with Robust Revenue Growth

Investors looking to capitalize on burgeoning opportunities in the healthcare sector may want to keep a close eye on Neurocrine Biosciences, Inc. (NBIX). With a market capitalization of $15.31 billion,..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 51.78% Potential Upside in Healthcare Investments

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, specifically in the medical instruments and supplies industry, presents an intriguing investment opportunity with a notable potential..

Danaher Corporation (DHR) Stock Analysis: Potential 46% Upside Amid Strong Buy Ratings

Danaher Corporation (NYSE: DHR) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $121.14 billion, Danaher operates a..

Humana Inc. (HUM): Investor Outlook Reveals Revenue Growth and Analyst Ratings Amidst Potential Downside

As Humana Inc. (NYSE: HUM) continues to navigate the complex landscape of healthcare plans, investors are taking a closer look at the company’s financial health and market position. With a..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a pioneering force in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $159.39 billion,..

Edwards Lifesciences (EW) Stock Analysis: Exploring a Robust Healthcare Investment with 21.5% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW) stands as a formidable entity within the healthcare sector, specializing in innovative medical devices for cardiovascular disease treatment. With a market capitalization of $46.04 billion,..

Genmab A/S (GMAB) Stock Analysis: Unpacking the 42% Upside Potential

For investors eyeing the biotechnology sector, Genmab A/S (GMAB) presents a compelling opportunity with a potential upside of 42.01%. With its roots firmly planted in Denmark, this innovative company is..

Penumbra, Inc. (PEN) Stock Analysis: Navigating a 12.76% Upside in the Medical Devices Sector

As Penumbra, Inc. (NYSE: PEN) continues to carve out its niche in the dynamic healthcare sector, investors are keenly watching its performance. With a market capitalization of $12.67 billion, this..

Universal Health Services, Inc. (UHS) Stock Analysis: Poised for a 31% Upside with Strategic Healthcare Expansion

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, has captured investor attention with its potential upside of 31.39%, as indicated by analyst ratings. With a..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Unveiling a 67.64% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology firm, is drawing significant attention from investors with an enticing potential upside of 67.64%. Despite a current trading price of $54.06, a..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a Potential 14% Upside Amid Strong Revenue Growth

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, commands a substantial market capitalization of $532.77 billion, positioning it as a formidable player in the drug manufacturing industry...

United Therapeutics Corporation (UTHR) Stock Analysis: A 17.28% Upside Potential Beckons Investors

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, operates within the specialized niche of drug manufacturing. With a market capitalization of $23.98 billion, the company has..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 41% Upside Potential Amid Robust Healthcare Growth

Alcon Inc. (NYSE: ALC), a leading player in the medical instruments and supplies industry, is making waves in the healthcare sector with its innovative eye care products. Headquartered in Geneva,..

Sanofi (SNY) Stock Analysis: 29% Potential Upside and a Robust Dividend Yield

Sanofi (SNY), the French pharmaceutical giant, continues to draw attention from investors with its diverse portfolio and promising market position. Operating in the healthcare sector, specifically within the general drug..

Bristol-Myers Squibb (BMY): Investor Outlook Reveals 12.75% Upside Potential Amidst Stable Growth

Bristol-Myers Squibb Company (NYSE: BMY) remains a compelling consideration for investors eyeing the healthcare sector, particularly in the drug manufacturing space. With a market cap of $114.68 billion, the company..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth Potential with a 27.92% Upside

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, is capturing the attention of savvy investors with its impressive growth trajectory and strong upside potential. With a market..

Takeda Pharmaceutical (TAK) Stock Analysis: Strong Buy Ratings and a 25.67% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, is one of the leading players in the specialty and generic drug manufacturing industry. Headquartered in Tokyo, Japan,..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and 33.55% Potential Upside Propel Investor Interest

Cardinal Health, Inc. (NYSE: CAH), a leading player in the healthcare sector, operates across two main segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. With a market..

Search

Funds

May 11, 2026

Search

Funds

May 11, 2026

FTSE 100

Funds